Work-related stress: the hidden pandemic in pharmacy Data from our salary and job satisfaction survey paint a disturbing picture of a profession drowning in rising demand, staff shortages and shifting expectations.…
Antibiotic-resistant bloodstream infections fall for first time in five years A report by the UK Health Security Agency has revealed that the overall proportion of infections resistant to one or more antibiotics in England has risen since 2016.…
NHS deal makes direct oral anticoagulants available to more than 600,000 extra patients According to NHS England, the procurement deal would save money on the price of the medicines, and produce savings from a consequent reduction in strokes.…
RPS to cease all fossil fuel investments by the end of 2022 The Royal Pharmaceutical Society Assembly agreed that its previous approach, to encourage companies to improve their environmental principles, "was not great enough to balance out the negative impacts of climate change".…
Approaching difficult situations: how to have challenging conversations A guide, including example audio dialogue, on how to deal with challenging conversations that can arise in pharmacy practice.…
Study results show blood test could predict treatment response in people with prostate cancer Researchers looked at circulating tumour cells in blood samples to identify changes in response to chemotherapy treatment.…
Selective serotonin reuptake inhibitors reduce mortality in patients with COVID-19, study suggests Data from 3,401 patients with COVID-19 who took selective serotonin reuptake inhibitors showed that the relative risk of mortality was reduced by 28% in those treated with fluoxetine.…
Viktor Menka (1986–2021)On 31 August 2021, Viktor Menka, aged 35 years, of Croydon, South London. Mr Menka registered with the Society in 2020.…
How we became the top naloxone-supplying pharmacy in the country How one pharmacy’s no-nonsense approach to naloxone supply has helped to build vital trust in the community and potentially save lives.…
COVID-19 booster programme expands to include people aged over 40 years The Joint Committee on Vaccination and Immunisation has also said those aged 16–17 years, who are not in an at-risk group, should receive a second dose of COVID-19 vaccine.…
